Mitsuteru Hiwatari
Overview
Explore the profile of Mitsuteru Hiwatari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
213
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Takasugi N, Uchida K, Shimoda K, Watanabe E, Kato S, Hiwatari M, et al.
Pediatr Blood Cancer
. 2024 Sep;
71(11):e31309.
PMID: 39228072
No abstract available.
2.
Watanabe K, Tasaka K, Ogata H, Kato S, Ueno H, Umeda K, et al.
Cancer Gene Ther
. 2024 Apr;
31(7):1049-1059.
PMID: 38622340
Novel therapeutic strategies are urgently required for osteosarcoma, given the early age at onset and persistently high mortality rate. Modern transcriptomics techniques can identify differentially expressed genes (DEGs) that may...
3.
Goto Y, Higuchi F, Hiwatari M, Sasajima Y, Shin M
World Neurosurg
. 2024 Apr;
186:165.
PMID: 38575060
A mixed germ cell tumor (MGCT) in the neurohypophysis is very rare, with only a few reported cases but none with surgical videos. In this report, the endoscopic endonasal transsphenoidal...
4.
Kubota H, Ueno H, Tasaka K, Isobe T, Saida S, Kato I, et al.
Blood Adv
. 2023 Dec;
8(5):1258-1271.
PMID: 38127276
Aberrant micro-RNA (miRNA) expression profiles have been associated with disease progression and clinical outcome in pediatric cancers. However, few studies have analyzed genome-wide dysregulation of miRNAs and messenger RNAs (mRNAs)...
5.
Imai C, Sato A, Hiwatari M, Shimomura Y, Hori T, Suenobu S, et al.
Int J Hematol
. 2023 Apr;
118(1):99-106.
PMID: 37037958
The characteristics and prognosis of Japanese children with acute lymphoblastic leukemia (ALL) who fail to achieve complete remission after remission induction chemotherapy (i.e., experience induction failure) are poorly understood. Therefore,...
6.
Shirai R, Osumi T, Keino D, Nakabayashi K, Uchiyama T, Sekiguchi M, et al.
Int J Hematol
. 2023 Mar;
117(6):910-918.
PMID: 36867356
Minimal residual disease (MRD) is usually defined as the small number of cancer cells that remain in the body after treatment. The clinical significance of MRD kinetics is well recognized...
7.
Irie M, Niihori T, Nakano T, Suzuki T, Katayama S, Moriya K, et al.
Int J Hematol
. 2022 Dec;
117(4):598-606.
PMID: 36515795
Mutations in the MECOM encoding EVI1 are observed in infants who have radioulnar synostosis with amegakaryocytic thrombocytopenia. MECOM-associated syndrome was proposed based on clinical heterogeneity. Allogeneic hematopoietic stem cell transplantation...
8.
Watanabe K, Kimura S, Seki M, Isobe T, Kubota Y, Sekiguchi M, et al.
Oncogene
. 2022 Nov;
41(46):4994-5007.
PMID: 36319669
Neuroblastomas require novel therapies that are based on the exploitation of their biological mechanism. To address this need, we analyzed the DNA methylation and expression datasets of neuroblastomas, extracted a...
9.
Isobe T, Takagi M, Sato-Otsubo A, Nishimura A, Nagae G, Yamagishi C, et al.
Nat Commun
. 2022 Aug;
13(1):4501.
PMID: 36042201
KMT2A-rearranged infant acute lymphoblastic leukemia (ALL) represents the most refractory type of childhood leukemia. To uncover the molecular heterogeneity of this disease, we perform RNA sequencing, methylation array analysis, whole...
10.
Geier C, Ellison M, Cruz R, Pawar S, Leiss-Piller A, Zmajkovicova K, et al.
J Clin Immunol
. 2022 Aug;
42(8):1748-1765.
PMID: 35947323
Warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome (WS) is a combined immunodeficiency caused by gain-of-function mutations in the C-X-C chemokine receptor type 4 (CXCR4) gene. We characterize a unique international...